Mo-99 supply put at risk by COVID-19 pandemic

April 7, 2020, 10:18AMNuclear News

The U.S. healthcare industry is warning that the COVID-19 pandemic may threaten supplies of the medical radioisotope molybdenum-99, whose decay product, technetium-99m, is considered the workhorse isotope in nuclear medicine for diagnostic imaging. The online magazine Radiology Business recently reported that the American Society of Nuclear Cardiology (ASNC) alerted its members on April 1 that it is monitoring supply shortages of Mo-99 “more closely than ever” during the pandemic.

To continue reading, log in or create a free account!

DOE rolls out simplified HALEU enrichment RFP, opens door to LEU from allies

January 10, 2024, 12:01PMNuclear News

The Department of Energy issued a final request for proposals (RFP) on January 9 for uranium enrichment services to help establish a commercial domestic supply of high-assay low-enriched...

TerraPower partners with UEC for uranium supply

November 30, 2023, 3:00PMNuclear News

TerraPower and Uranium Energy announced today that they have signed a memorandum of understanding to “explore the potential supply of uranium” for TerraPower’s demonstration reactor in...

ANS Annual Meeting: Focus on the merits of advanced nuclear fuel cycles

June 29, 2023, 3:01PMNuclear News

Advanced reactors may be key to a clean energy future, but to prove it they’re going to need fuel—and that fuel will be derived from limited uranium resources and managed throughout the...

Westinghouse, TerraPower join the Ac-225 supply chain

June 29, 2023, 9:30AMNuclear News

Westinghouse and TerraPower, in conjunction with Belgium’s Pan Tera, have announced plans to produce large quantities of actinium-225, a radioisotope used for targeted alpha radiation...

Serva Energy teams with research reactor to produce cancer-fighting Ac-225

June 27, 2023, 7:00AMNuclear News

Serva Energy has developed a research reactor–based method of actinium-225 production, the company announced on June 22, saying it “marks the first time a commercial entity has employed a...

World Astatine Community expands access to cancer-fighting At-211

June 20, 2023, 12:00PMNuclear News

The World Astatine Community (WAC) was formed earlier this year during the 12th International Symposium for Targeted Alpha Therapy by representatives from the United States, Japan, and the...

NNSA announces progress in Mo-99 production using LEU

April 4, 2023, 7:00AMANS Nuclear Cafe

After more than a decade of global efforts led by the Department of Energy’s National Nuclear Security Administration, all four major medical producers of the radioisotope molybdenum-99 for...

Requested NRC budget tops $1 billion

March 24, 2023, 12:00PMNuclear News

The White House’s recently released budget request for fiscal year 2024 would provide $1.006 billion in gross budget authority for the Nuclear Regulatory Commission—an increase of $63.2...

Senate hearing focuses on securing the entire U.S. nuclear fuel cycle

March 14, 2023, 9:39AMNuclear News

“Right now, our country is deficient in nearly every aspect of the fuel cycle. This must change and it must change quickly,” said Sen. Joe Manchin (D., W.V.), chairman of the Senate...

SHINE's final SER for Wisconsin facility issued by NRC

March 1, 2023, 12:00PMNuclear News

The Nuclear Regulatory Commission has issued its final safety evaluation report (SER) related to the operating license application for SHINE Technologies' large-scale medical isotope...

Mo-99 supply put at risk by COVID-19 pandemic

Related Articles